Neuroprotective effect of Dl-3-n-butylphthalide against ischemia–reperfusion injury is mediated by ferroptosis regulation via the SLC7A11/GSH/GPX4 pathway and the attenuation of blood–brain barrier disruption

Stroke is one of the most severe diseases worldwide, resulting in physical and mental problems. Dl-3-n-butylphthalide, a compound derived from celery seed, has been approved for treating ischemic stroke in China. No study has evaluated how Dl-3-n-butylphthalide affects the ferroptosis SLC7A11/GSH/GPX4 signal pathway and blood–brain barrier (BBB) PDGFRβ/PI3K/Akt signal pathways in the rat middle cerebral artery occlusion/reperfusion (MCAO/R) model of ischemic stroke.Sprague–Dawley rats were used to develop the MCAO/R model. Our study used three incremental doses (10, 20, and 30) of Dl-3-n-butylphthalide injected intraperitoneally 24 h after MCAO/R surgery. The neuroprotective effect and success of the model were evaluated using the neurofunction score, brain water content determination, and triphenyl-tetrazolium chloride-determined infarction area changes. Pathological changes in the brain tissue and the degree of apoptosis were examined by hematoxylin and eosin, Nissl, and terminal deoxynucleotidyl transferase dUTP nick end labeling staining. In addition, pathway proteins and RNA expression levels were studied to verify the effects of Dl-3-n-butyphthalide on both pathways. At the same time, commercial kits were used to detect glutathione, reactive oxygen species, and malondialdehyde, to detect oxidative stress in brain tissues.The middle dose of Dl-3-n-butylphthalide not only improved MCAO-induced brain dysfunction and alleviated pathological damage, brain inflammatory response, oxidative stress, and apoptosis but also protected against ferroptosis and reduced BBB damage. These changes resulted in improved neurological function in the cerebral cortex.We speculate that Dl-3-n-butylphthalide has a neuroprotective effect on focal cerebral ischemia/reperfusion, which may be mediated through ferroptosis-dependent SLC7A11/GSH/GPX4 signal pathway and PDGFRβ/PI3/Akt signal pathway.

[1]  P. Pan,et al.  Selenium Alleviates Cerebral Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Fusion and Ferroptosis , 2022, Neurochemical Research.

[2]  Zhenlang Lin,et al.  Ferroptosis is Involved in Hypoxic-ischemic Brain Damage in Neonatal Rats , 2022, Neuroscience.

[3]  Guobing Chen,et al.  Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance , 2022, Stroke and vascular neurology.

[4]  Yun-bi Zhang,et al.  Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis , 2022, Frontiers in Pharmacology.

[5]  Jieqiong Du,et al.  Efficacy of sequential N-butylphthalide therapy on psychiatric and behavioral functions in acute ischemic stroke , 2021, Medicine.

[6]  Dong Zhang,et al.  Neuroprotective and Anti-Inflammatory Effect of Pterostilbene Against Cerebral Ischemia/Reperfusion Injury via Suppression of COX-2 , 2021, Frontiers in Pharmacology.

[7]  Ling Wei,et al.  DL-3-n-butylphthalide Increases Collateriogenesis and Functional Recovery after Focal Ischemic Stroke in Mice , 2021, Aging and disease.

[8]  Ping Zhang,et al.  Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice , 2021, Frontiers in Pharmacology.

[9]  Anding Xu,et al.  Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry , 2021, Frontiers in Neurology.

[10]  Juan Feng,et al.  Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target? , 2021, ASN neuro.

[11]  A. Buchan,et al.  Top Priorities for Cerebroprotective Studies: A Paradigm Shift. , 2021, Stroke.

[12]  G. Kroemer,et al.  Ferroptosis in infection, inflammation, and immunity , 2021, The Journal of experimental medicine.

[13]  K. Aoyama.  Glutathione in the Brain , 2021, International journal of molecular sciences.

[14]  Zhiping Hu,et al.  L-3-n-butylphthalide promotes restoration after an experimental animal model of intracerebral hemorrhage , 2021, International journal of medical sciences.

[15]  Jian-yong Yin,et al.  Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury. , 2021, Biochemical and biophysical research communications.

[16]  Guibo Sun,et al.  Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke , 2021, Oxidative medicine and cellular longevity.

[17]  A. Belaidi,et al.  Ferroptosis: mechanisms and links with diseases , 2021, Signal Transduction and Targeted Therapy.

[18]  G. Kroemer,et al.  Cellular degradation systems in ferroptosis , 2021, Cell Death & Differentiation.

[19]  A. Mamun,et al.  DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress , 2021, Acta Pharmacologica Sinica.

[20]  L. Birnbaumer,et al.  Quercetin alleviates acute kidney injury by inhibiting ferroptosis , 2020, Journal of advanced research.

[21]  Chaoliang Tang,et al.  Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFβ/ALK1/Smad1/5 signaling pathway , 2020, Aging.

[22]  Xu Wang,et al.  Mechanism of Ferroptosis and Its Relationships With Other Types of Programmed Cell Death: Insights for Potential Interventions After Intracerebral Hemorrhage , 2020, Frontiers in Neuroscience.

[23]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[24]  D. Klionsky,et al.  Ferroptosis: machinery and regulation , 2020, Autophagy.

[25]  Bin Lan,et al.  Cross Talk Between Ferroptosis and Cerebral Ischemia , 2020, Frontiers in Neuroscience.

[26]  P. Lei,et al.  The pathological role of ferroptosis in ischemia/reperfusion-related injury , 2020, Zoological research.

[27]  Jianping Chen,et al.  Total Glycosides of Cistanche deserticola Promote Neurological Function Recovery by Inducing Neurovascular Regeneration via Nrf-2/Keap-1 Pathway in MCAO/R Rats , 2020, Frontiers in Pharmacology.

[28]  Yu He,et al.  Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt Pathway , 2020, Frontiers in Pharmacology.

[29]  B. Stockwell,et al.  Transferrin Receptor Is a Specific Ferroptosis Marker , 2020, Cell reports.

[30]  Zongjian Liu,et al.  Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti‐inflammatory phenotype through STAT3 pathway , 2019, CNS neuroscience & therapeutics.

[31]  Zhen Wang,et al.  Simvastatin preparations promote PDGF‐BB secretion to repair LPS‐induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway , 2019, Journal of cellular and molecular medicine.

[32]  Zongze Zhang,et al.  Effects of irisin on the dysfunction of blood–brain barrier in rats after focal cerebral ischemia/reperfusion , 2019, Brain and behavior.

[33]  Wiendelt Steenbergen,et al.  Clinical applications of laser speckle contrast imaging: a review , 2019, Journal of biomedical optics.

[34]  Xiaolin Huang,et al.  Electroacupuncture Alleviates Ischemic Brain Injury by Inhibiting the miR-223/NLRP3 Pathway , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[35]  J. Baron,et al.  Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era. , 2019, Stroke.

[36]  B. Stockwell,et al.  The development of the concept of ferroptosis. , 2019, Free radical biology & medicine.

[37]  K. Sheng,et al.  PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia , 2018, Molecular medicine reports.

[38]  Guihua Xu,et al.  PDGFR-β restores blood-brain barrier functions in a mouse model of focal cerebral ischemia , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  Tianjie Yuan,et al.  Protective Effect of Anthocyanin on Neurovascular Unit in Cerebral Ischemia/Reperfusion Injury in Rats , 2018, Front. Neurosci..

[40]  H. Das,et al.  Current advances in ischemic stroke research and therapies. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[41]  R. J. Hayes,et al.  ‘Allocation concealment’: the evolution and adoption of a methodological term , 2018, Journal of the Royal Society of Medicine.

[42]  Qitao Ran,et al.  Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration , 2017, Redox biology.

[43]  J. Kou,et al.  Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway , 2016, International journal of molecular sciences.

[44]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[45]  S. Dixon,et al.  Mechanisms of ferroptosis , 2016, Cellular and Molecular Life Sciences.

[46]  C. Kleinschnitz,et al.  Animal models of ischemic stroke and their application in clinical research , 2015, Drug design, development and therapy.

[47]  Likun Ma,et al.  Role of PDGFR-β/PI3K/AKT signaling pathway in PDGF-BB induced myocardial fibrosis in rats. , 2014, American journal of translational research.

[48]  R. Perera,et al.  The Need for Randomization in Animal Trials: An Overview of Systematic Reviews , 2014, PloS one.

[49]  Jun Wang,et al.  3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia , 2014, Neural regeneration research.

[50]  E. Kremmer,et al.  System xc− and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency* , 2010, The Journal of Biological Chemistry.

[51]  Annie P. Moseman,et al.  PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. , 2007, The Journal of clinical investigation.